Outbreak readiness Integrum Scientific positions itself as an outbreak readiness and response partner with mobile laboratories, on-site testing capabilities, and power/communication solutions in challenging environments. This suggests opportunities to sell field-deployable lab equipment, portable testing kits, and remote connectivity solutions to governments, NGOs, and biotech customers seeking rapid on-site diagnostics.

Global collaboration The company maintains an Infectious Disease Scientific Advisory Board with global ties and partnerships in Africa, Europe, and Canada, plus pre-negotiated local government agreements. This network can be leveraged to secure pilot projects, co-development agreements, and regional implementation contracts through introductions and trusted relationships.

Clinical and field expertise With experience conducting pivotal outbreak-related research and offering study design, program management, monitoring, field training, and biobanking, Integrum can upsell end-to-end research services, capacity-building programs, and regulatory-aligned study implementations to biotech firms, CROs, and governments seeking rapid outbreak-ready clinical research.

Public sector alignment Active engagement with global initiatives, World Vaccine Congress participation, and CEPI collaborations indicate strong alignment with public health agendas and funding streams. This opens opportunities for grant-enabled projects, funded pilots, and large-scale vaccine/therapeutic countermeasure programs with government and multilateral agencies.

Mobile lab solutions The capability to collect and test samples on site, plus ensuring power and communications where infrastructure is limited, points to potential sales of mobile lab platforms, biobanking services, and on-site logistics support to NGOs, humanitarian missions, and regional health authorities seeking rapid outbreak response capacity.